Who has invested in Capsida?

AbbVie, Versant Ventures, Westlake Village BioPartners are named among the investors backing Capsida.

Capsida Funding: $140M Raised, Series A (2021)

Capsida funding overview

Capsida is based in Thousand Oaks, CA. Capsida has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for Capsida runs through 2021; nothing later has been disclosed. Investors on record include AbbVie, Versant Ventures, Westlake Village BioPartners. 3 distinct backers are named across the disclosed rounds.

Capsida at a glance

Total raised: $140M
Latest round: Series A
Latest round date: April 2021
Headquarters: Thousand Oaks, CA
Notable investors: AbbVie, Versant Ventures, Westlake Village BioPartners

Frequently asked about Capsida funding

How much has Capsida raised?: Capsida has raised $140M in total disclosed funding across the rounds on record.
Who has invested in Capsida?: AbbVie, Versant Ventures, Westlake Village BioPartners are named among the investors backing Capsida.
What was the latest Capsida funding round?: The most recent disclosed round is a Series A, announced in April 2021.
Where is Capsida based?: Capsida is based in Thousand Oaks, CA.
When did Capsida last raise?: The last disclosed Capsida round closed in April 2021 at Series A.

Every Capsida figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Thousand Oaks at a similar stage.

Capsida Funding: $140M Raised, Series A (2021)

Capsida funding overview

Capsida at a glance

Frequently asked about Capsida funding

Companies related to Capsida (13)

Browse related funding lists (5)